150 related articles for article (PubMed ID: 33847541)
41. Evaluation of government strategies against COVID-19 pandemic using q-rung orthopair fuzzy TOPSIS method.
Alkan N; Kahraman C
Appl Soft Comput; 2021 Oct; 110():107653. PubMed ID: 34226821
[TBL] [Abstract][Full Text] [Related]
42. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
[TBL] [Abstract][Full Text] [Related]
43. Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.
Bailly M; Mieczkowski C; Juan V; Metwally E; Tomazela D; Baker J; Uchida M; Kofman E; Raoufi F; Motlagh S; Yu Y; Park J; Raghava S; Welsh J; Rauscher M; Raghunathan G; Hsieh M; Chen YL; Nguyen HT; Nguyen N; Cipriano D; Fayadat-Dilman L
MAbs; 2020; 12(1):1743053. PubMed ID: 32249670
[TBL] [Abstract][Full Text] [Related]
44. Sustainable supply chain partner selection and order allocation: A hybrid fuzzy PL-TODIM based MCGDM approach.
Zhong S; Zhang J; He X; Liu S
PLoS One; 2022; 17(9):e0271194. PubMed ID: 36137146
[TBL] [Abstract][Full Text] [Related]
45. Desirability-based methods of multiobjective optimization and ranking for global QSAR studies. Filtering safe and potent drug candidates from combinatorial libraries.
Cruz-Monteagudo M; Borges F; Cordeiro MN; Cagide Fajin JL; Morell C; Ruiz RM; Cañizares-Carmenate Y; Dominguez ER
J Comb Chem; 2008; 10(6):897-913. PubMed ID: 18855460
[TBL] [Abstract][Full Text] [Related]
46. A Multicriteria-Based Comparison of Electric Vehicles Using q-Rung Orthopair Fuzzy Numbers.
Biswas S; Sanyal A; Božanić D; Kar S; Milić A; Puška A
Entropy (Basel); 2023 Jun; 25(6):. PubMed ID: 37372249
[TBL] [Abstract][Full Text] [Related]
47. Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.
Wolf Pérez AM; Lorenzen N; Vendruscolo M; Sormanni P
Methods Mol Biol; 2022; 2313():57-113. PubMed ID: 34478132
[TBL] [Abstract][Full Text] [Related]
48. Multi-criteria decision-making for coronavirus disease 2019 applications: a theoretical analysis review.
Alsalem MA; Alamoodi AH; Albahri OS; Dawood KA; Mohammed RT; Alnoor A; Zaidan AA; Albahri AS; Zaidan BB; Jumaah FM; Al-Obaidi JR
Artif Intell Rev; 2022; 55(6):4979-5062. PubMed ID: 35103030
[TBL] [Abstract][Full Text] [Related]
49. Machine learning for detecting COVID-19 from cough sounds: An ensemble-based MCDM method.
Chowdhury NK; Kabir MA; Rahman MM; Islam SMS
Comput Biol Med; 2022 Jun; 145():105405. PubMed ID: 35318171
[TBL] [Abstract][Full Text] [Related]
50. Additive manufacturing process selection for automotive industry using Pythagorean fuzzy CRITIC EDAS.
Menekse A; Ertemel AV; Camgoz Akdag H; Gorener A
PLoS One; 2023; 18(3):e0282676. PubMed ID: 36893100
[TBL] [Abstract][Full Text] [Related]
51. An integrated CRITIC-TOPSIS- and Entropy-TOPSIS-based informative weighting and ranking approach for evaluating green energy sources and its experimental analysis on pyrolysis.
Lakshmi BM; Mathew M; Kinol AMJ; Vedagiri B; Perumal SB; Madhu P; Dhanalakshmi CS
Environ Sci Pollut Res Int; 2022 Aug; 29(40):61370-61382. PubMed ID: 35445298
[TBL] [Abstract][Full Text] [Related]
52. An application of a hybrid MCDM method for the evaluation of entrepreneurial intensity among the SMEs: a case study.
Rostamzadeh R; Ismail K; Bodaghi Khajeh Noubar H
ScientificWorldJournal; 2014; 2014():703650. PubMed ID: 25197707
[TBL] [Abstract][Full Text] [Related]
53. A simple way to unify multicriteria decision analysis (MCDA) and stochastic multicriteria acceptability analysis (SMAA) using a Dirichlet distribution in benefit-risk assessment.
Saint-Hilary G; Cadour S; Robert V; Gasparini M
Biom J; 2017 May; 59(3):567-578. PubMed ID: 28187230
[TBL] [Abstract][Full Text] [Related]
54. Hospital selection framework for remote MCD patients based on fuzzy q-rung orthopair environment.
Alamoodi AH; Albahri OS; Zaidan AA; Alsattar HA; Zaidan BB; Albahri AS
Neural Comput Appl; 2023; 35(8):6185-6196. PubMed ID: 36415285
[TBL] [Abstract][Full Text] [Related]
55. Consensus scoring criteria for improving enrichment in virtual screening.
Yang JM; Chen YF; Shen TW; Kristal BS; Hsu DF
J Chem Inf Model; 2005; 45(4):1134-46. PubMed ID: 16045308
[TBL] [Abstract][Full Text] [Related]
56. Fuzzy MCDM models for selection of the tourism development site: the case of Azerbaijan.
Nuriyev AM
F1000Res; 2022; 11():310. PubMed ID: 35350546
[No Abstract] [Full Text] [Related]
57. Evaluating the Investment Projects of Spinal Medical Device Firms Using the Real Option and DANP-mV Based MCDM Methods.
Huang CY; Hsieh HL; Chen H
Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32403356
[TBL] [Abstract][Full Text] [Related]
58. User-Driven Strategy for In Silico Screening of Reversed-Phase Liquid Chromatography Conditions for Known Pharmaceutical-Related Small Molecules.
Van Laethem T; Kumari P; Boulanger B; Hubert P; Fillet M; Sacré PY; Hubert C
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500399
[TBL] [Abstract][Full Text] [Related]
59. Universal screening for SARS-CoV-2 infection: a rapid review.
Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
